Organicell Regenerative Medicine, Inc.

Organicell Regenerative Medicine, Inc.verified

OCEL

Price:

$2.7425

Market Cap:

$19.97M

Organicell Regenerative Medicine, Inc., a clinical-stage biopharmaceutical company, focuses on the development of biological therapeutics for the treatment of degenerative diseases. Its leading product candidate is Zofin, an acellular, biologic therapeutic derived from perinatal sources and is manufactured to retain naturally occurring microRNAs without the addition or combination of any other substance or diluent, which is in Phase I/II clinical trial to treat COVID-19. The company also provides independent education, advertising, and marketing services to medical and other healthcare, anti-aging, and regenerative service providers. It has a research and development agreement with the Cente...[Read more]

Industry

Biotechnology

IPO Date

2016-03-01

Stock Exchange

PNK

Ticker

OCEL

The ROE as of November 2024 (TTM) for Organicell Regenerative Medicine, Inc. (OCEL) is 239.48%

According to Organicell Regenerative Medicine, Inc.’s latest financial reports and current stock price. The company's current ROE is 239.48%. This represents a change of -30.71% compared to the average of 345.60% of the last 4 quarters.

Organicell Regenerative Medicine, Inc. (OCEL) Historical ROE (quarterly & annually)

How has OCEL ROE performed in the past?

The mean historical ROE of Organicell Regenerative Medicine, Inc. over the last ten years is -332.46%. The current 239.48% ROE has changed -172.03% with respect to the historical average. Over the past ten years (40 quarters), OCEL's ROE was at its highest in in the April 2023 quarter at 1.49%. The ROE was at its lowest in in the October 2015 quarter at -2723.60%.

Quarterly (TTM)
Annual

Average

-332.46%

Median

206.14%

Minimum

-5746.84%

Maximum

919.19%

Organicell Regenerative Medicine, Inc. (OCEL) ROE by Quarter and Year

Discovering the peaks and valleys of Organicell Regenerative Medicine, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 668.59%

Maximum Annual ROE = 919.19%

Minimum Annual Increase = -4663.19%

Minimum Annual ROE = -5746.84%

Quarterly (TTM)
Annual
YearROEChange
2023562.98%-218.80%
2022-473.90%-198.54%
2021480.94%-47.68%
2020919.19%668.59%
2019119.59%-56.55%
2018275.25%9.12%
2017252.24%57.62%
2016160.04%-102.78%
2015-5746.84%-4663.19%
2014125.94%-144.36%

Organicell Regenerative Medicine, Inc. (OCEL) Average ROE

How has OCEL ROE performed in the past?

The current ROE of Organicell Regenerative Medicine, Inc. (OCEL) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

3-year avg

190.01%

5-year avg

321.76%

10-year avg

-332.46%

Organicell Regenerative Medicine, Inc. (OCEL) ROE vs. Peers

How is OCEL’s ROE compared to its peers?

Organicell Regenerative Medicine, Inc.’s ROE is greater than Cellectis S.A. (-76.69%), greater than Biotron Limited (-504.53%), less than Awakn Life Sciences Corp. (175.85%), greater than TC Biopharm (Holdings) Plc (-442.56%), less than Bioasis Technologies Inc. (0%), greater than BetterLife Pharma Inc. (0%), less than Covalon Technologies Ltd. (46.88%), greater than Protara Therapeutics, Inc. (-4.23%), greater than Vaccinex, Inc. (-55.96%), less than Monopar Therapeutics Inc. (1.93%), greater than Miromatrix Medical Inc. (-21731.73%), greater than Surrozen, Inc. (-70.01%), greater than null (-222.75%),

Build a custom stock screener for Organicell Regenerative Medicine, Inc. (OCEL) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Organicell Regenerative Medicine, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Organicell Regenerative Medicine, Inc. (OCEL) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Organicell Regenerative Medicine, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Organicell Regenerative Medicine, Inc.'s ROE?

How is the ROE calculated for Organicell Regenerative Medicine, Inc. (OCEL)?

What is the highest ROE for Organicell Regenerative Medicine, Inc. (OCEL)?

What is the 3-year average ROE for Organicell Regenerative Medicine, Inc. (OCEL)?

What is the 5-year average ROE for Organicell Regenerative Medicine, Inc. (OCEL)?

How does the current ROE for Organicell Regenerative Medicine, Inc. (OCEL) compare to its historical average?